Caryl Meade
Pfizer (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability, T-cell and B-cell Immunology
Most-Cited Works
- → Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer(2016)94 cited
- → Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins(2018)44 cited
- → Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors(2021)15 cited
- → Expression, purification and characterization of the human membrane transporter protein OATP2B1 from Sf9 insect cells(2007)11 cited
- → Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization(2023)9 cited
- → Large-Scale Transient Production in ExpiCHO-S™ with Enhanced N-Galactosylation-Sialylation and PEI-Based Transfection(2021)6 cited
- → Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4(2024)4 cited
- → Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation(2022)3 cited
- → A ’Coomassie for Carbohydrates” – Novel Methodology for Rapid Detection and Quantitation of Glycosylated IgGs on an SDS-PAGE Gel(2023)1 cited
- → A ‘Coomassie for Carbohydrates” - novel methodology for rapid detection and quantitation of glycosylated IgGs on an SDS-PAGE gel(2023)